IGEA and the research

Science, innovation, efficacy, technology, quality, and safety are the guiding criteria for the development of innovative medical devices working in collaboration with physicians and medical teams. 

Constant intellectual effort and scientific development have created a research path aimed at introducing new therapies and continuously improving existing ones.

Basic research

Transposon-Based, Targeted Ex Vivo Gene Therapy to Treat Age-Related Macular Degeneration (TargetAMD) [European Commission: FP7-HEALTH-2012-INNOVATION-1]

Creazione di un’infrastruttura multiregionale (italian regenerative medicine infrastructure) per lo sviluppo delle terapie avanzate finalizzate alla rigenerazione d’organi e tessuti (all’interno del Cluster Scienze della Vita) [MIUR, Cluster Tecnologici Nazionali, IRMI]

Innovativo ElettroPoratore MultiFunzione (EPMF) per la generazione di impulsi arbitrari da impiegare per il trasferimento di materiale genico dentro le cellule. [MISE]

Deploiable-expandable Electrode for ElectroPoration of cancer cells [MISE]

Oncology research

Electrochemotherapy on Head and Neck Cancer. [NCT02549742]
Electrochemotherapy for the Inoperable Vulva Carcinoma. [NCT03142061]

Treatment of Primary Liver Tumors with Electrochemotherapy (ECT) [NCT02291133]

Electrochemotherapy with Bleomycin for the Treatment of Unresectable Pancreatic Cancer. [NCT03225781]

Electrochemotherapy for Breast Cancer Patients with Skin Metastases. [ISRCTN56719146]

Orthopaedics research

Can Clinical and Surgical Parameters be Combined to Predict how long it will take a Tibia Fracture to Heal? A prospective multicentre observational study. The FRACTING (tibia FRACTure prediction healING days) Study. [ISRCTN10831351]

I-ONE Therapy in Patients Undergoing Total Knee Arthroplasty: a Prospective, Randomized and Controlled Study. [ISRCTN10526056]

Neurology research

A Multicentric, Prospective, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effectiveness of Low-Frequency Pulsed Electromagnetic Fields (ELF-MF) in Acute Ischemic Stroke. [NCT02767778]

The contents of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice because of something you have read on this website.
This website does not recommend or endorse any specific tests, physicians, medical products, procedures, opinions, or other information that may be mentioned on the Site.
The site and its contents are provided on an "as is" basis by the public communication department of IGEA S.p.A.

IGEA © 2020